<DOC>
	<DOC>NCT01467791</DOC>
	<brief_summary>Registry to follow patients with sarcoidosis associated pulmonary hypertension</brief_summary>
	<brief_title>Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)</brief_title>
	<detailed_description>This is a multi center registry of sarcoidosis associated pulmonary hypertension (SAPH). With this registry, the investigators will characterize the demographics, clinical course, hemodynamics, pulmonary physiology, and disease management of sarcoidosis associated pulmonary hypertension on the United States. The investigators will also compare these features to non-US sites.</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension, Pulmonary</mesh_term>
	<mesh_term>Sarcoidosis</mesh_term>
	<criteria>Patients with sarcoidosis as defined by the ATS/WASOG statement Patients with pulmonary hypertension as confirmed by right heart catheterization Patients willing to provide written informed consent Unwillingness to provide assurance that they will complete the follow up visits for the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>ambrisentan</keyword>
	<keyword>Bosentan</keyword>
	<keyword>Iloprost</keyword>
</DOC>